MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Cognitive dysfunction"

  • MDS Virtual Congress 2020

    Candidate plasma miRNAs and EV protein as novel biomarkers in Parkinson’s disease patients with cognitive impairment and dementia

    R.M Wu, Y.Z Tsai, M.C Kuo, Y.u Yoshioka, K.j Ueda, T.k Ochiya, S.P Lin (Taipei, Taiwan)

    Objective: To determine the diagnostic value of circulating miRNAs and the extracellular vesicle proteins for early detection of patients with Parkinson’s disease and mild cognitive…
  • MDS Virtual Congress 2020

    Graph theory analysis of dopamine D2 receptor network in Parkinson’s disease patients

    A. Mihaescu, J. Kim, S. Cho, M. Diez-Cirarda, M. Valli, Y. Koshimori, A. Strafella (Toronto, ON, Canada)

    Objective: The aim of this study was to explore a novel method of analyzing positron emission tomography (PET) data using graph theory analysis. To this…
  • MDS Virtual Congress 2020

    Dysphasia as a novel approach for classification of speech disorders in Parkinson’s disease and other forms of neurodegeneration

    E. Vasenina, O. Levin (Moscow, Russian Federation)

    Objective: To classify and identify the features of speech disorders in Parkinson's disease and other neurodegenerative diseases. Background: No unified approach to classification and diagnostics…
  • MDS Virtual Congress 2020

    Measure of Social Relation in Huntington’s Disease: The Relationship Self-Questionnaire (RSQ)

    J. Hamet Bagnou, R. Massart, K. Hernandez, R. Fliss, M. Lunven, E. Audureau, A.C Bachoud-Levi (Creteil, France)

    Objective: Development and validation of the Relationship Self-Questionnaire (RSQ), specific to Huntington’s disease (HD), which aims tomeasurepatients self-perceived quality of their relationships (RS). Background: In…
  • MDS Virtual Congress 2020

    Impulsivity and Compulsivity in Cerebellar Ataxias

    N. Amokrane, A. Viswanathan, S. Freedman, C. Yang, S. Kuo, C. Lin (New York, NY, USA)

    Objective: To elucidate the role of human cerebellum in the reward processing system, of which a new cerebellar circuitry was recently identified in mice [1].…
  • MDS Virtual Congress 2020

    Role of Sex in Parkinson’s Disease Progression

    E. Bayram, S. Eberly, D. Oakes, I. Litvan (La Jolla, CA, USA)

    Objective: To investigate the sex differences for disease progression in Parkinson’s disease (PD). Background: Prevalence and symptom profile in PD differ between women and men.…
  • MDS Virtual Congress 2020

    Anxiety disorders are associated with verbal memory impairment in Parkinson’s disease

    N. Dissanayaka, E. Forbes, J. Yang, J. O'Sullivan, D. Copland, K. McMahon, L. Mitchell, G. Byrne (Brisbane, Australia)

    Objective: The present study aimed to investigate the association between anxiety disorders and memory impairment in Parkinson’s disease.The present study aimed to investigate the association…
  • MDS Virtual Congress 2020

    Comparative analysis of cognitive function between unilaterally and bilaterally affected Parkinson’s disease

    J. Lee, G.S Kim (Goyang-si, Republic of Korea)

    Objective: To compare the cognitive function between unilateral and bilateral PD to identify whether worse cognitive impairment underlies in the bilateral group who had greater…
  • MDS Virtual Congress 2020

    The feasibility of cognitive telerehabilitation in patients with Parkinson´s disease: The pilot data

    V. Plzáková (Prague, Czech Republic)

    Objective: The aim of this study was to focus on the feasibility and potential benefits of cognitive telerehabilitation (CTR) in patients with Parkinson´s disease (PD).…
  • MDS Virtual Congress 2020

    Identification and clinical characteristics of Mild Cognitive Impairment in Parkinson’s disease

    J. Yang, E. Forbes, D. Pourzinal, K. McMahon, D. Copland, G. Byrne, J. O'Sullivan, L. Mitchell, N. Dissanayaka (Herston, Australia)

    Objective: To examine the characteristics of mild cognitive impairment in Parkinson’s disease (PD) patients with mild cognitive impairment (MCI) Background: Cognitive disturbances in PD detrimentally…
  • « Previous Page
  • 1
  • …
  • 56
  • 57
  • 58
  • 59
  • 60
  • …
  • 128
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley